Coronavirus: Usa buy quarterly production remdesivir – Ultima Ora

0
7


(ANSA) – ROME, JULY 01 – The American administration has
almost the entire quarterly production of the drug is ensured
remdesivir produced by the US company Gilead Sciences:
the BBC reports.

As is known, the antiviral had been studied initially
against Ebola, but its use has already been approved by the authorities
Americans for treatment against Covid-19 and the week
Last also the European Medicines Agency (Ema) gave the
own consent, which must now be ratified by the
European Commission.

President Donald Trump has signed an agreement
“extraordinary” with Gilead for 500,000 doses of remdesivir, he said
the Health Department announced in a press release. Yes
deals with the entire Gilead production for the month of
July, 90% of August production and 90% of that
of September.

A course of treatment with this drug takes on average
6.25 ampoules. (HANDLE).

RESERVED REPRODUCTION © Copyright ANSA


Please enter your comment!
Please enter your name here